Supplementary Figure S1 from A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance

Authors :: Norman H. Lee
Johng Rhim
Kenneth Nguyen
Patricia Latham
Tessa Knox
Youngmi Ji
Kaitlin Garofano
Lana X. Garmire
Travers Ching
Bi-Dar Wang
Jacqueline Olender
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: S1. Prostate cancer cells overexpressing FGFR3-S are resistance to the combination of dovitinib- and docetaxel-induced apoptotic activity.

Full Text Access

Tools